Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease

101Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In postmortem Huntington's disease brains, mutant htt is present in both nuclear and cytoplasmic compartments. To dissect the impact of nuclear and extranuclear mutant htt on the initiation and progression of disease, we generated a series of transgenic mouse lines in which nuclear localization or nuclear export signal sequences have been placed N-terminal to the htt exon 1 protein carrying 144 glutamines. Our data indicate that the exon 1 mutant protein is present in the nucleus as part of an oligomeric or aggregation complex. Increasing the concentration of the mutant transprotein in the nucleus is sufficient for and dramatically accelerates the onset and progression of behavioral phenotypes. Furthermore, nuclear exon 1 mutant protein is sufficient to induce cytoplasmic neurodegeneration and transcriptional dysregulation. However, our data suggest that cytoplasmic mutant exon 1 htt, if present, contributes to disease progression. © The Author 2005. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Benn, C. L., Landles, C., Li, H., Strand, A. D., Woodman, B., Sathasivam, K., … Bates, G. P. (2005). Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington’s disease. Human Molecular Genetics, 14(20), 3065–3078. https://doi.org/10.1093/hmg/ddi340

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free